CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Growing geriatric population base
4.1.2. Increase in the number of CROS, forensic and research laboratories
4.1.3. Increasing demand for prenatal genetic testing procedures
4.1.4. Technological advancements in PCR
4.2. Market Restraints & Challenges
4.2.1. High device cost associated with qPCR and dPCR
4.2.2. Adoption and implementation of Miqe guidelines for publishing qPCR and dPCR based research
4.3. Market Opportunities
4.3.1. The shift from plant-derived to genome-based drug discovery
4.3.2. Growing market penetration in emerging countries
CHAPTER 5 GLOBAL DIGITAL PCR AND REAL-TIME PCR MARKET – BY PRODUCT AND
SERVICE
5.1. Introduction
5.2. dPCR products and services
5.2.1. dPCR instruments
5.2.2. dPCR reagents and consumables
5.2.3. dPCR software and services
5.3. qPCR products and services
5.3.1. qPCR reagents and consumables
5.3.2. qPCR instruments
5.3.3. qPCR software and services
CHAPTER 6 GLOBAL DIGITAL PCR AND REAL-TIME PCR MARKET – BY TECHNOLOGY
6.1. Introduction
6.2. Quantitative PCR
6.3. Digital PCR
CHAPTER 7 GLOBAL DIGITAL PCR AND REAL-TIME PCR MARKET – BY APPLICATION
7.1. Introduction services
7.2. qPCR applications
7.2.1. Clinical applications
7.2.1.1. Pathogen testing
7.2.1.2. Oncology testing
7.2.1.3. Blood screening
7.2.1.4. Other clinical applications
7.2.2. Research applications
7.2.3. Forensic applications
7.3. dPCR Applications
7.3.1. Clinical applications
7.3.1.1. Pathogen testing
7.3.1.2. Oncology testing
7.3.1.3. Blood screening
7.3.1.4. Other clinical applications
7.3.2. Research applications
7.3.3. Forensic applications
CHAPTER 8 GLOBAL DIGITAL PCR AND REAL-TIME PCR MARKET - BY END USER
8.1. Introduction
8.2. Quantitative PCR (qPCR) end users
8.2.1. Hospitals and diagnostic centers
8.2.2. Research laboratories and academic institutes
8.2.3. Pharmaceutical and biotechnology companies
8.2.4. Clinical research organizations
8.2.5. Forensic laboratories
8.3. Digital PCR (dPCR) end users
8.3.1. Research laboratories and academic institutes
8.3.2. Hospitals and diagnostic centers
8.3.3. Pharmaceutical and biotechnology companies
8.3.4. Clinical research organizations
8.3.5. Forensic laboratories
CHAPTER 9 GLOBAL DIGITAL PCR AND REAL-TIME PCR MARKET - BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. Asia Pacific
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10 GLOBAL DIGITAL PCR AND REAL-TIME PCR MARKET - COMPANY PROFILES
10.1. Affymetrix, Inc.
10.2. Thermo Fisher Scientific, Inc.
10.3. Bio-Rad Laboratories Inc.
10.4. Qiagen N.V
10.5. Qiagen N.V
10.6. Abbott Laboratories, Inc.
10.7. Cepheid Inc.
10.8. Agilent Technologies, Inc.
10.9. GE Healthcare.,
10.10. Biomérieux S.A.
10.11. Hoffman-La Roche.
10.12. Fluidigm Corporation.
10.13. Promega Corporation.
10.14. Becton, Dickinson and Company
10.15. The Merck Group.
CHAPTER 11 GLOBAL DIGITAL PCR AND REAL-TIME PCR MARKET - COMPETITIVE
LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12 MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13 APPENDIX
13.1. List of Tables
13.2. List of Figures
